On June 8, 2021 Australian cancer diagnosis and treatment hopeful Clarity Pharmaceuticals reported that it has hired investment banks Jefferies and Bell Potter to manage an initial public offering that could value it at about $300 million (Press release, Clarity Pharmaceuticals, JUN 23, 2021, View Source [SID1234586804]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

It is understood Clarity Pharmaceuticals has told investors it is preparing offer documents for a $60 million-odd raising at about a $250 million pre-money valuation, with funds raised used for clinical trials and to commercialise its products.